Resolution Therapeutics is a biotechnology company developing macrophage cell therapy to treat inflammatory organ disease. The company was founded following a productive collaboration between Edinburgh’s Centre for Regenerative Medicine, the Scottish National Blood Transfusion Service, and Syncona Investment Management Limited. The company is based in the Centre for Regenerative Medicine on the Edinburgh Royal Infirmary Campus, and is backed by Syncona.
Our initial focus is in chronic liver disease. It is the only chronic disease still on the rise in western countries, and affects millions of people worldwide. Unfortunately, only supportive therapies are currently available. For patients with end-stage liver disease (cirrhosis) the only therapeutic option is liver transplantation, a complex surgical procedure limited by complications and a shortage of donors. At Resolution Therapeutics, we are developing a macrophage cell therapy product to treat patients at risk of liver decompensation, thus helping them avoid the need for a liver transplant.
Our initial focus is in chronic liver disease. It is the only chronic disease still on the rise in western countries, and affects millions of people worldwide. Unfortunately, only supportive therapies are currently available. For patients with end-stage liver disease (cirrhosis) the only therapeutic option is liver transplantation, a complex surgical procedure limited by complications and a shortage of donors. At Resolution Therapeutics, we are developing a macrophage cell therapy product to treat patients at risk of liver decompensation, thus helping them avoid the need for a liver transplant.
Employees: 11-50
Total raised: $83.37M
Founded date: 2020
Investors 1
| Date | Name | Website |
| - | Syncona Pa... | synconaltd... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 03.10.2024 | Series B | $83.37M | - |
Mentions in press and media 3
| Date | Title | Description |
| 30.01.2025 | VC Investment in Scottish Startups Rose by 14% in Q4 2024 | The value of venture capital (VC) investment in Scottish startups increased by 14% in the final quarter of 2024, according to KPMG’s latest Venture Pulse report. A total of £92.3 million was raised by the country’s startups from October to ... |
| 03.10.2024 | Resolution Therapeutics Raises £63.5M in Series B Financing | Resolution Therapeutics, an Edinburgh, Scotland, and London, UK-based clinical-stage biopharmaceutical company, raised £63.5M in Series B funding. The round was led by Syncona Ltd. Alongside the financing, Resolution also announced the appo... |
| - | Resolution Therapeutics | “Unlocking regenerative macrophage therapy” |